Menu
Menu
J Clin Aesthet Dermatol. 2022;15(6):59-64. by Ty Gilkey, BS; John Trinidad, MD; Claire Kovalchin, BS; Abena Minta, BS; Misha Rosenbach, MD; and Benjamin H. Kaffenberger, MD Mr. Gilkey, Ms. Kovalchin,
Dear Editor: Dulaglutide is a glucagon-like peptide (GLP-1) receptor agonist, which stimulates insulin release via activation of GLP-1 receptors on pancreatic beta cells. Here, we report the first case of
